Public antibody sequence database
Search traceable antibody variable-region sequences and connect them directly to recombinant expression, purification and fluorescent labeling. The launch set includes 10 high-demand oncology and immunology research antibodies.
- Launch set
- 10 Public-sequence antibodies
- Sequence fields
- VH/VL Traceable public-source records
- Service pathway
- Custom Expression · purification · labeling
Pembrolizumab
PD-1 / CD279 · PDCD1
Atezolizumab
PD-L1 / CD274 · CD274
Trastuzumab
HER2 / CD340 · ERBB2
Rituximab
CD20 · MS4A1
Daratumumab
CD38 · CD38
Cetuximab
EGFR / HER1 · EGFR
Ipilimumab
CTLA-4 / CD152 · CTLA4
Tafasitamab
CD19 · CD19
Belantamab
BCMA / CD269 · TNFRSF17
Sacituzumab
TROP-2 · TACSTD2
Public sequences with an executable delivery path
The database makes sequences searchable and sources traceable. Project services turn a selected public sequence into a recombinant or fluorescently labeled research antibody.
- 01
Sequence check
Review the public source, chain type, variable-region completeness and construct design.
- 02
Recombinant expression
Begin production after confirming the constant region, expression scale and purification approach.
- 03
Fluorescent labeling
Select a channel from the available dye portfolio, then complete conjugation, purification and agreed basic quality checks.